Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

SB 590885

Name SB 590885
Supplier R&D Systems
Catalog 2650
Prices $235.00, $965.00
Sizes 10 mg, 50 mg
Cas Number 405554-55-4
Chemical Name 5-[2-[4-[2-(Dimethylamino)ethoxy]phenyl]-5-(4-pyridinyl)-1H-imidazol-4-yl]-2,3-dihydro-1H-inden-1-oneoxime
Formula C27H27N5O2
Molecular Weight 453.54
Purity >98%
Supplier Page Shop

Product References

Drug-based modulation of endogenous stem cells promotes functional remyelination - Drug-based modulation of endogenous stem cells promotes functional remyelination

Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ. Nature. 2015 Jun 11;522(7555):216-20.

Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase - Resistance to vemurafenib resulting from a novel mutation in the BRAFV600E kinase

Wagenaar TR, Ma L, Roscoe B, Park SM, Bolon DN, Green MR. Pigment Cell Melanoma Res. 2014 Jan;27(1):124-33.

A modified HSP70 inhibitor shows broad activity as an anticancer agent. - A modified HSP70 inhibitor shows broad activity as an anticancer agent.

Balaburski GM, Leu JI, Beeharry N, Hayik S, Andrake MD, Zhang G, Herlyn M, Villanueva J, Dunbrack RL Jr, Yen T, George DL, Murphy ME. Mol Cancer Res. 2013 Mar;11(3):219-29.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved